India's apex drugs regulator, the Central Drugs Standard Control Organization (CDSCO) is all set for a makeover with a new name and logo.

Apple Watch Series 4 can perform ECGs, monitor heart rates, detect falls and contact emergency services if required.

Apple is all set to broadcast the launch of the new iPhones from the event being conducted at Apple Park in Cupertino. The mega-tech company is estimated to launch three new iPhones.

Vedanta bags 41 of 55 oil blocks in maiden open acreage auction; Johnson & Johnson has been slapped with penalty in the US for faulty hip replacements; and housing units worth Rs 4.64 lakh crore delayed in 7 top cities. BusinessToday.In Editor Rajeev Dubey explains this and more on The Good, The Bad and The Ugly.

Ministry of Health and Family Welfare has asked the drug regulator - central drug standard control organisation - to set up committees in states to receive complaints from patients who were affected by Johnson & Johnson's faulty devices.

How Malvinder and Shivinder Singh blew Rs 22,500 crore in less than a decade and lost control over Fortis Healthcare and Religare Enterprises.

The Dr Reddy's stock fell up to 10.61% or 246 points to 2,071.50 level. The stock closed 9.85% or 228 points lower at 2089.15 on the BSE.

The prosecution argued that Johnson & Johnson were aware that its talc is contaminated with asbestos since 1970s but did not warn their customers about the risks involved.

Officials at Sun Pharmaceutical Industries heaved a sigh of relief in mid-June after the United States Food and Drug Administration (FDA)pronounced that the firm's plant in Halol, Gujarat was cleared.

The stock has been gaining for the last eight days and has risen 20.08% in the period. It opened with a gain of 2.23% today. The stock has gained every month in the last seven months and has generated 20.02% returns in the period.

The development is a hugely positive development both for Sun Pharma and for Indian pharma. From a sentiment perspective, it is significant given that the company has been finally able to get its facility cleared after three years.

Vikas Jain, Senior Research Analyst, Reliance Securities, takes viewers through all the market action this week. Shares of Sun Pharma surged over 8 per cent on Friday after the US health regulator did not recommend any action against the company's Halol plant in Gujarat.

The inspection team, which inspected the facilities between February 2-23, gave a 'voluntary action indicated' (VAI) remark to Sun's Halol plant in Gujarat.

VAI status means that though objectionable conditions were found at the plant, the issues do not justify further regulatory action and any corrective action is left to the FDA to take voluntarily.